Wangda Zhou
Publications by Year
Research Areas
Pharmaceutical studies and practices, Pharmacogenetics and Drug Metabolism, Psoriasis: Treatment and Pathogenesis, Blood Coagulation and Thrombosis Mechanisms, Pharmacology and Obesity Treatment
Most-Cited Works
- → Tropolones As Lead-Like Natural Products: The Development of Potent and Selective Histone Deacetylase Inhibitors(2013)99 cited
- → Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children(2017)75 cited
- → Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata(2014)50 cited
- → Protein-Based MRI Contrast Agents for Molecular Imaging of Prostate Cancer(2010)31 cited
- → Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis(2016)29 cited
- → Antifolates as effective antimicrobial agents: new generations of trimethoprim analogs(2013)28 cited
- → Physiologically Based Pharmacokinetic Modeling to Evaluate the Systemic Exposure of Gefitinib in CYP2D6 Ultrarapid Metabolizers and Extensive Metabolizers(2017)20 cited
- → Utilization of physiologically‐based pharmacokinetic model to assess disease‐mediated therapeutic protein‐disease‐drug interaction in immune‐mediated inflammatory diseases(2021)14 cited
- → Acetylenic Linkers in Lead Compounds: A Study of the Stability of the Propargyl-Linked Antifolates(2012)13 cited
- → Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study(2021)12 cited